|
1
|
Deans RJ and Moseley AB: Mesenchymal stem
cells: Biology and potential clinical uses. Exp Hematol.
28:875–884. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Phinney DG and Prockop DJ: Concise review:
Mesenchymal stem/multipotent stromal cells: The state of
transdifferentiation and modes of tissue repair-current views. Stem
Cells. 25:2896–2902. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Glennie S, Soeiro I, Dyson PJ, Lam EW and
Dazzi F: Bone marrow mesenchymal stem cells induce division arrest
anergy of activated T cell. Blood. 105:2821–2827. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ren G, Su J, Zhang L, Zhao X, Ling W,
L'huillie A, Zhang J, Lu Y, Roberts AI, Ji W, et al: Species
variation in the mechanisms of mesenchymal stem cell-mediated
immunosuppression. Stem Cells. 27:1954–1962. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sotiropoulou PA, Perez SA, Gritzapis AD,
Baxevanis CN and Papamichail M: Interactions between human
mesenchymal stem cells and natural killer cells. Stem Cells.
24:74–85. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jiang XX, Zhang Y, Liu B, Zhang SX, Wu Y,
Yu XD and Mao N: Human mesenchymal stem cells inhibit
differentiation and function of monocyte-derived dendritic cells.
Blood. 105:4120–4126. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gronthos S, Franklin DM, Leddy HA, Robey
PG, Storms RW and Gimble JM: Surface protein characterization of
human adipose tissue derived stromal cells. J Cell Physiol.
189:54–63. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bassi E, Aita CA and Câmara NO: Immune
regulatory properties of multipotent mesenchymal stromal cells:
Where do we stand? World J Stem Cell. 3:1–8. 2011. View Article : Google Scholar
|
|
10
|
Rasmusson I: Immune modulation by
mesenchymal stem cells. Exp Cell Res. 312:2169–2179. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Herzog EL, Chai L and Krause DS:
Plasticity of marrow-derived stem cells. Blood. 102:3483–3493.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kharaziha P, Hellström PM, Noorinayer B,
Farzaneh F, Aghajani K, Jafari F, Telkabadi M, Atashi A, Honardoost
M, Zali MR and Soleimani M: Improvement of liver function in liver
cirrhosis patients after autologous mesenchymal stem cell
injection: A phase I–II clinical trial. Eur J Gastroenterol
Hepatol. 21:1199–1205. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Z, Lin H, Shi M, Xu R, Fu J, Lv J,
Chen L, Lv S, Li Y, Yu S, et al: Human umbilical cord mesenchymal
stem cells improve liver function and ascites in decompensated
liver cirrhosis patients. J Gastroenterol Hepatol. 2 Suppl
27:S112–S120. 2012. View Article : Google Scholar
|
|
14
|
Vojtassák J, Danisovic L, Kubes M, Bakos
D, Jarábek L, Ulicná M and Blasko M: Autologous biograft and
mesenchymal stem cells in treatment of the diabetic foot. Neuro
Endocrinol Lett. 2 Suppl 27:S134–S137. 2006.
|
|
15
|
Djouad F, Plence P, Bony C, Tropel P,
Apparailly F, Sany J, Noël D and Jorgensen C: Immunosuppressive
effect of mesenchymal stem cells favors tumor growth in allogeneic
animals. Blood. 102:3837–3844. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Le Blanc K, Frassoni F, Ball L, Locatelli
F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger
M, et al: Mesenchymal stem cells for treatment of
steroid-resistant, severe, acute graft-versus-host disease: A phase
II study. Lancet. 371:1579–1586. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu S, Ju GQ, Du T, Zhu YJ and Liu GH:
Mcirovesicles derived from human umbilical cord Wharton's jelly
mesenchymal stem cells attenuate bladder tumor cell growth in vitro
and in vivo. PLoS One. 8:e613662013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu J, Han G, Liu H and Qin C: Suppression
of cholangiocarcinoma cell growth by human umbilical cord
mesenchyaml stem cells: A possible role of wnt and Akt signaling.
PLoS One. 8:e628442013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kabashima-Niibe A, Higuchi H, Takaishi H,
Masugi Y, Matsuzaki Y, Mabuchi Y, Funakoshi S, Adachi M, Hamamoto
Y, Kawachi S, et al: Mesenchymal stem cells regulate
epithelial-mesenchymal transition and tumor progression of
pancreatic cancer cells. Cancer Sci. 104:157–164. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang T, Lee YW, Rui YF, Cheng TY, Jiang
XH and Li G: Bone marrow-derived mesenchymal stem cells promote
growth and angiogenesis of breast and prostate tumors. Stem Cell
Res Ther. 4:702013. View
Article : Google Scholar : PubMed/NCBI
|
